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The resident microbes of human gastrointestinal tract cause both harmful and
beneficial effects and these effects can be modulated by the administration of beneficial
probiotic bacteria. Probiotics attribute several therapeutic and preventive beneficial
effects, for both humans and animals. Despite the good effects of probiotic bacteria, the
role of probiotic bacteria or their metabolites on the nutrient uptake by enterocytes is very
less known. Most studies describe the genomic effects of probiotic bacteria on the
transport properties. This thesis describes the short term (10 min or less) non-genomic
effects of probiotic bacteria on the glucose uptake by human enterocytes like Caco-2
cells. The focus of the present study was to identify if metabolites of Lactobacilli sp.
trigger a rapid non genomic regulation of glucose transporter proteins of enterocytes. The
findings indicate that the regulatory molecules of bacterial metabolites can cause a rapid
increase in glucose uptake by enterocytes.
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CHAPTER I
LITERATURE REVIEW
Microbial Ecology of the Gut
The human intestine can be considered as a small, but complex and diverse
microbial ecosystem. The microbes resident in the gastrointestinal tract (GIT) represent
about 90% of total cell count (1014 cells) of the human body and the human colon
accommodates at least 400 bacterial species (38). Under optimal healthy condition, there
are continuous interactions among the enteropathogenic bacteria, the beneficial
commensal bacteria, and the human gut. These interactions deemed microbial-epithelial
“crosstalk”, play important roles in determining the health and disease status of the host.
The enteric pathogens and their toxic metabolites constantly try to penetrate the
gut barrier and enter the host. The interactions between pathogenic bacteria and the host
intestine involves several signaling pathways that lead to disruption of the cytoskeleton
and the tight junctions that link epithelial cells and trigger the entry of the pathogens (22).
Many of the pathogenic bacteria have a common mechanism of action to induce harmful
effects in the host’s body. Toxins secreted by pathogens affect epithelial cells by
disrupting the integrity of the cytoskeleton and cell functions. They also induce changes
in enzyme functions, production of proinflammatory molecules, and the secretion of fluid
and electrolytes (48).
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The commensal gut flora plays an important role in the defense mechanisms of
the small and large intestines. This role includes the degradation of non-digestible food
particles (79), stimulation of the host immune system to secrete more secretory IgA (21),
and competition with the enteric pathogens for adhesion sites and nutrients (31).
Maintaining a balance between the commensal and pathogenic bacteria is very important
for maintaining the intestinal equilibrium and health of the body. Unfortunately, the
modern day lifestyle, including western food habits, and increased use of antibiotics has
disturbed the microbial homeostasis of the gut (25). As a consequence, there have been
reductions in the densities of beneficial health supporting bacteria and increases in
pathogenic microorganisms, such as Clostridium sp., Salmonella sp., and Vibrio
cholerae. It is not surprising that an elevation of the health promoting beneficial bacteria
in the gut is considered to be important for maintaining a good health status. This concept
supports and justifies the regular use of probiotics to increase the proportion of beneficial
bacteria and thereby reduce the incidence and severity of diseases.

Probiotic Bacteria - Definition and Classification
The Greek word probiotic literally means “for life”. The term probiotic was first
coined in 1965 and was explained as metabolites produced by one microorganisms which
stimulate the growth of other bacteria (51). The definition was modified in 1991 and
according to this definition, probiotics are viable microorganisms which when ingested,
dead or alive, in proper amounts provide beneficial effects by improving the properties of
indigenous microbes and potentially improve the health of their human hosts (26).
2

Probiotics typically include members of the indigenous beneficial gut flora which are
isolated, characterized, evaluated, and ultimately used for therapeutic purposes.
Probiotics are available in the market in the form of various fermented dairy products
such as yogurt, buttermilk, cheese and also in the form of dietary supplements such as
powders, capsules, and tablets. The daily dose of probiotics necessary to provide the
optimum benefits is generally considered to be between 106 and 109 colony-forming units
(74).
The most commonly used probiotics are lactic acid producing bacteria such as
Lactobacilli sp., Bifidobacteria sp. and Enterococcus sp (47). Other bacterial species
used as probiotics include Lactococcus sp. (92), Clostridium butyricum (85), and
Streptococcus thermophilus (72). The Lactobacilli are an important and the most
commonly used probiotic genus. Representative species are Lactobacilli acidophilus, L.
johnsonii, L. gasseri, L. gallinarum, L. casei, L. plantarum, L. rhamnosus GG, L.
crispatus, L. reuteri, and L. bulgaricus. Bifidobacteria contribute the largest group of
beneficial bacteria in the large intestine, and are also used as probiotics. Some of the
more important members of this genus that are used as probiotics are Bifidobacteria
bifidum, B. breve, B. infantis, and B. longum (28). Other bacteria which have been
considered as probiotics are Enterococcus faecium, Escherichia coli Nissle 1917, and
Streptococcus salivarius subsp. thermophilus. Saccharomyces boulardii, a nonpathogenic
yeast also inhibits the colonization of harmful bacteria and has been categorized as a
probiotic (77).
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The Mechanism of Action of Probiotic Bacteria
Probiotic bacteria confer beneficial effects to the host by several different
mechanisms of action. The fermentation of carbohydrates by probiotic bacteria produces
lactic acid and other short chain fatty acids, such as acetate, butyrate, and propionate,
which decrease the pH of the gut and inhibit the growth of pathogenic microorganisms
(25). Some probiotic bacteria such as B. longum and L. acidophilus provide antioxidant
properties by inhibiting linoleic acid peroxidation and by scavenging free radicals (53).
The lactic acid producing bacteria also produce bacteriocins that inhibit the growth of
harmful bacteria such as Helicobacter pylori, Escherichia coli O157:H7 (EHEC), and
Salmonella enterica var. Typhimurium (2, 12, 55). Probiotic bacteria also compete with
the pathogens for mucosal surface binding sites. For example, L. casei Shirota and L.
rhamnosus GG displace enterovirulent E. coli and Salmonella enterica var. Typhimurium
(49). Probiotic bacteria can induce the production of mucin in the small intestine by
upregulating the expression of the MUC-2 mucin gene and thereby inhibit the adherence
of enteropathogenic bacteria (59). Heat killed as well as live strains of probiotic bacteria
induce the expression of human beta defensin–2 which is a small peptide with a broad
spectrum of antimicrobial activity that is expressed with inflammation in ulcerative
colitis (96). Probiotic bacteria also inhibit the activation of nuclear factor-кB (NF-кB)
and induce heat shock proteins (hsps) in colonic epithelium cells by inhibition of
proteosomes (69). DNA microarray analysis has shown that long-term exposure to
commensal bacteria up-regulates a vast array of intestinal genes that are involved in
postnatal maturation of the intestine, absorption of nutrients, angiogenesis, and mucosal
4

barrier functions (39). Moreover, probiotic bacteria like Lactobacillus GG can regulate
gene expression by small intestinal mucosa. Specifically, after one month of
Lactobacillus GG consumption the expression of 334 genes was upregulated. Expression
of 92 other genes was down-regulated, and notably many of these were genes involved in
apoptosis, inflammation and immune responses, cell differentiation and cell adhesion,
cell-cell signaling, cell signaling transcription and transduction (16).

Beneficial Effects of Probiotic Bacteria
Probiotic bacteria have been used for the prevention and amelioration of viral,
antibiotic-related, and bacterial diarrhea. The duration of viral diarrhea was reduced by
administration of L rhamnosus GG, B. bifidum, and Streptococcus thermophilus (75, 88).
Receiving broad-spectrum antibiotics has a common side effect of diarrhea, which is
mainly due to disturbing the balance of the gut microbial flora. Administration of
probiotics such as L rhamnosus GG, L. acidophilus, L. bulgaricus, and Enterobacter
faecium reduces the duration and occurrence of antibiotic induced diarrhea (57). L
rhamnosus GG and S. boulardii significantly reduce the occurrence of traveler’s diarrhea
(88). Probiotic bacteria also reduce the symptoms of irritable bowel syndrome (IBS),
such as abdominal pain, bloating, flatulence, and diarrhea (44). Individual strains of
probiotic and mixtures of several probiotic species, such as VSL#3, significantly reduce
the symptoms of abdominal bloating and flatulence associated with IBS (44, 63).
The endogenous microbial flora plays an important role in inflammatory bowel
disease (IBD). The densities of lactobacilli are lower in patients with ulcerative colitis,
5

and the number of fecal Bifidobacteria are significantly reduced in subjects with
Crohn’s disease (23). The administration of probiotic bacterial preparations to IBD
patients diminishes the incidence of relapse of ulcerative colitis and pouchitis (78).
Probiotics have also been shown to reduce the occurrence and severity of necrotizing
enterocolitis in cases of infants born prematurely and also to reduce the incidence of
neonatal sepsis (52). Some probiotic bacteria are reported to inhibit the adhesion and
growth of harmful bacteria such as Helicobacter pylori. “Folk yogurt”, as reported by Oh
et al. (64), is a combination of yeast and lactobacilli which secretes soluble factors
capable of inhibiting H. pylori.

Glucose Transporters of Enterocytes
Carbohydrates are a component of the diet of humans and other omnivorous
animals. Digestible carbohydrates in the human diet are available in different forms, such
as monosaccharides (glucose, and fructose), disaccharides (lactose, sucrose, and maltose)
and polysaccharides. Gastrointestinal tract enzymes hydrolyze disaccharides and
digestible polysaccharides into monosaccharides that are then absorbed from the
intestinal lumen. The absorption of glucose by enterocytes is mediated partly by the
concentrative, high affinity, sodium glucose transporter SGLT1, which is powered by the
electrochemical gradient of Na+ that plays an important role in the ability of epithelial
cells to transport a wide variety of solutes from the lumen. The stoichiometry of glucose
transport is 2 Na+ per glucose. The Na+ gradient is established and maintained by Na+K+-ATPase present in the basolateral membrane of the gut epithelial cells.
6

SGLT1 is a 73 kDa plasma membrane protein that is localized in the brush
border membrane (BBM) of enterocytes, but not in the basolateral membrane (89).
SGLT1 has 662 amino acid residues with 14 transmembrane domains and both the N and
C termini are extracellular (89). SGLT1 also transports galactose with an affinity similar
to that for glucose, and can be inhibited by phloridzin. Other members of this transporter
family include SGLT2, which has a Na+-to-glucose coupling ratio of 1:1 and SGLT3,
which is a low affinity glucose transporter than may function more as a glucose sensor
(18). The physiological process of glucose transport starts with an initial binding of two
Na+ ions to SGLT1, causing a conformational change in the transporter proteins allowing
glucose to bind. Once the transporter is loaded with Na+ and glucose another
conformational change translocates the glucose and Na+ to the cytosolic side where they
dissociate from the transporter protein due to reduced affinity and to the low intracellular
concentration of Na+ ions. Phosphorylation sites located between transmembrane helices
6 and 7, and 8 and 9 (98) of SGLT1 are important for the transport of glucose across the
BBM.
Glucose that accumulates in the enterocyte is transported to the blood by glucose
transporters-2 (GLUT2) that is present in the basolateral membrane of enterocytes. When
the load of glucose in the intestinal lumen is high after a carbohydrate rich diet, then there
is translocation of GLUT2 to the apical membrane of enterocytes (43). The apical
translocation also occurs in the absorptive cells of proximal tubules of kidney (58). This
high capacity and low affinity glucose transporter is thought to facilitate the passive and
rapid absorption of glucose at high concentrations.
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There is another mechanism of nutrient absorption which is known as
paracellular absorption. The transport of nutrients through paracellular pathway is mainly
regulated by the permeability of tight junctions linking epithelial cells (67).
Electrophysiological studies of glucose uptake by SGLT1 showed that there is an
increase of surface area of tight junctions after the transport of nutrients by Na+-coupled
transporter proteins (65). The increased permeability of tight junctions after Na+-coupled
nutrient transport also increases water flow across the tight junctions. The simultaneous
increases in water flow and paracellular permeability are purported to increase the
paracellular transport of nutrients (67). Besides water movement, several peptides also
use the paracellular pathway to be absorbed from the intestinal lumen (66).

The Regulation of Glucose Transporters
The densities and the activities of the glucose transporter proteins determine the
rate of glucose uptake across the BBM of enterocytes. There are numerous factors that
influence transporter densities and activities. These include diet composition, species,
stage of development, health status, and a variety of host derived signaling molecules.
Dietary upregulation of glucose transporters was induced by switching mice to a
carbohydrate rich diet (17). The regulation of glucose transporters is also species specific.
For example, the level of dietary carbohydrate regulates the activities of transporters in
mammals, amphibians and fish, except in most birds like American robins (50) and house
sparrows (8). This may be due to a greater dependency of birds on passive absorption of
glucose by paracellular pathway. Intestinal transport of glucose depends on the
8

developmental stages of individuals. During gestational development, glucose uptake
increases by 3-fold in rabbits (70). The active transport of glucose is also regulated by the
health status of an individual. For example, glucose uptake is reduced in some diseased
conditions such as short bowel syndrome and post gastrectomy malabsorption (24).
Several host derived molecules such as epidermal growth factors (11), insulin like growth
factors (1), and glucagon like peptide-2 increase (10) glucose uptake by stimulating
enterocytes to express more transporter proteins.
The regulation of glucose transporter proteins can occurs over three time scales evolutionary, developmental, and immediate. The process of evolution from bacteria to
mammals is the longest time scale for regulation of the glucose transporter proteins. The
structure-functional analysis of glucose transporters reveals that environmental factors
had a great role in the evolution of the glucose transporter family. The differences in the
activities and substrate affinities among the transporters is mainly due to mutations that
alter particular amino acid residues (95). Under the time scale of developmental stages,
there are changes in the uptake of glucose and other nutrients due to increases of
absorptive surface area and mucosal mass, and changes in the types and densities of
transporters for sugars and other nutrients (24). Again during development, glucose
transport is highly regulated by the nature of diet, with carbohydrate rich diets inducing
the expression of glucose transporters (17).
Enterocytes have the ability to rapidly regulate the transporter proteins (11, 35,
43). Immediate regulation can involve genomic mechanisms that require from 30 min to
several days for complete adaptation. Genomic regulation requires the expression of
9

transporter genes and changes the total number of particular transporter proteins in the
cells. Genomic regulation is mediated by several factors such as changes in dietary levels
of sugars (60), protein kinase A (99) and protein kinase C (99), AMP-activated kinase
(94), cyclic AMP (13, 83), glucagon-like peptide 2 (10, 76), insulin (84), polyamines
(91), short chain fatty acids (61), heat shock proteins (41), transforming growth factor β
(41), and cytokines (34, 56). These factors modulate glucose uptake by increasing or
decreasing the production of transporters. Enterocytes also have the ability to rapidly and
reversibly regulate the transporter proteins in the BBM. This rapid regulation occurs in
<10 min and does not require the synthesis of new transporter proteins. Hence, it is
considered as a non-genomic mechanism of transporter regulation. The ability to rapidly
regulate the transporter proteins allows enterocytes to adapt to the changes in luminal
nutrient concentrations that occur before, during, and after the processing of meals. Nongenomic regulation of glucose transporters is dependent on the rapid translocation of
existing transporters from a cytosolic source to the BBM where they are inserted (46).
Alternatively, non-genomic regulation may involve the reversible activation of
transporters already resident in the BBM (73). The majority of studies examining
transporter regulation have focused on the genomic mechanisms of adaptation. Far fewer
studies have investigated the rapid non-genomic regulation of transporter proteins.
Moreover, most of the non-genomic studies performed to date have used time periods of
30 to 60 min, which is sufficiently long for the expression and insertion of new
transporter proteins into the BBM (32, 36). There is a need for studies that examine rapid
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(<10 min) regulation of the transporters by epithelial cells and are unequivocally nongenomic.

Probiotic Bacteria and Nutrient Uptake by Enterocytes
There are many studies which described several therapeutic effects of probiotic
bacteria (5, 77, 93), but very few studies have examined the influence of probiotic
bacteria on nutrient uptake by intestinal epithelial cells. The following is a review of what
is known. Breves et al.(4) report an upregulatory effect of probiotics Saccharomyces
boulardii and Bacillus cereus on Na+ coupled glucose transport by the jejunum of pigs.
These findings are corroborated by the upregulation of intestinal Na+ coupled glucose
transport and barrier properties of piglets receiving probiotic Enterococcus faecium (54).
A study by Schroeder et al. (80) described how S. boulardii decreased total ion transport
by the pig jejunum after eight days of providing probiotic supplements. A recent in vitro
study using human enterocyte like Caco-2 cells reported that the probiotics Lactobacillus
salivarius and Bifidobacterium infantis enhance transepithelial calcium uptake (30).
Collectively, these studies provide evidence of the role of probiotic bacteria in increasing
nutrient uptake and improving barrier functions of the small intestine. However, because
of the prolonged administration of or exposure to the probiotics (6 h to days and weeks),
the changes in enterocyte functions can be attributed to the genomic regulation of
transporters. At the present time there are no studies that have examined the potential of
probiotic bacteria to trigger rapid non-genomic regulation of nutrient transporters and
thereby the uptake of nutrients by enterocytes. There are precedents for the abilities of
11

bacteria to rapidly regulate enterocyte functions based on studies with pathogens.
Enteropathogenic bacteria have several strategies to rapidly exploit the different functions
of enterocytes by disrupting cell structure components, by hampering normal cell
absorptive and secretory functions, and by inducing several signaling pathways which
ultimately produce proinflammatory cytokines. Toxins secreted by enteropathogenic
bacteria induced changes in ion transport properties of enterocytes. For example,
enterotoxins from E. coli and V. cholerae activate different signaling pathways that
trigger increased Cl¯ secretion. These toxins regulate the secretion of different ions by
activating Gs proteins that stimulate adenylate cyclase or guanylate cyclase and thereby
alter the activity of K+ channels, cystic fibrosis transmembrane regulator (CFTR), and
sodium/hydrogen exchangers (3, 37, 48). In addition to regulating ion transport,
enteropathogenic bacteria stimulate the nutrient uptake by changing the activity of
transporters. For example, bacterial lipopolysaccharides increase glucose uptake in Caco2 cells by regulating the apical expression of glucose transporters (101). Importantly,
these responses occur rapidly and do not necessarily require changes in the abundances of
transporter proteins.
Therefore, the aim of the present in vitro study was to test the hypothesis that
probiotic Lactobacilli are able to rapidly regulate nutrient transport by enterocytes. This
was accomplished using glucose as a model nutrient and Caco-2 cells as a model for
enterocytes.

12

CHAPTER II
GLUCOSE UPTAKE ASSAY
INTRODUCTION
The complex and dynamic microbial ecology of the gastrointestinal tract (GIT)
and the indigenous microbiota play important roles in the health and well being of the
host. The resident microbiota cause both harmful and beneficial effects and these effects
can be modulated by the administration of beneficial probiotic bacteria. According to the
accepted definition, “Probiotics are selected microorganisms which when ingested, dead
or alive, in sufficient amounts provide beneficial effects by improving the properties of
the indigenous microbes” (27). The most commonly used probiotic microorganisms are
the lactic acid-producing bacteria (LAB), which include species of the genera
Lactobacillus sp., Bifidobacterium sp., and Enterococcus sp (47).
Probiotics provide several therapeutic and preventive effects, not only for
humans, but also for animals. These include reducing the occurrence and duration of
diarrhea associated with administration of antibiotics or the presence of pathogens (57,
75, 85), modulating the immune responses to a wide variety of antigens (68), lowering
serum cholesterol levels (29), increasing lactose tolerance (15), detoxification of harmful
microbial metabolites and dietary carcinogens (55), and providing metabolites that
promote intestinal health (88).
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Despite the reported beneficial effects of probiotic bacteria, there is very little known
about the direct effects of probiotic bacteria or their metabolites on enterocytes. Even less
is known about the influences of probiotics on enterocyte nutrient absorptive functions.
Schroeder et. al. (80) reported that Saccharomyces boulardii alters the electrical
properties and the chloride-mediated secretory responses of pig jejunum. In other studies,
Enterococcus faecium NCIMB 10415 has been shown to improve the transport and
barrier functions of the pig small intestine (35) and the probiotic bacteria Lactobacillus
salivarius and Bifidobacterium infantis enhance apical calcium uptake by Caco-2 cells
(30). All of these studies evaluated genomic effects of probiotic on the transport
properties of intestinal epithelial cells as the exposure times ranged from hours to several
days, which is sufficiently long for changes in protein abundances. Until now, no study
has been performed to determine the short term (10 min or less) non-genomic effects of
probiotic bacteria on the nutrient uptake properties of enterocytes.
In the light of the above, I investigated if the metabolites of probiotic Lactobacilli
altered nutrient uptake by Caco-2 cells, which are commonly used as a model for
enterocytes. The focus of the present study was to determine if metabolites of probiotic
species of Lactobacilli cause rapid (< 10 min) non-genomic regulation of BBM glucose
transporter proteins. The hypothesis was that metabolites of probiotic Lactobacilli would
trigger a rapid increase in the ability of Caco-2 cells to transport glucose. This was
accomplished by measuring glucose accumulation by Caco-2 cells that were exposed to a
chemically defined medium (CDM) before and after it had been used to culture
Lactobacillus sp. anerobically for 72 h. Rates of glucose uptake are a function of the
14

densities and activities of the transporter proteins in the BBM, such as the sodium
coupled glucose transporter 1 (SGLT1). Hence, rates of glucose accumulation by Caco-2
cells were used as an indicator of SGLT1 functions.

MATERIALS AND METHODS
Cell Culture
Caco-2 cells transfected to overexpress SGLT1, were obtained from Dr. Jerrold R.
Turner (Department of Pathology, The University of Chicago, Chicago, Illinois, USA).
The Caco-2 cell line was originally established from human adenocarcinoma cells which
differentiate spontaneously in cell culture media and acquire enterocyte characteristics
(71). In this study, Caco-2 cells were used between passages 22 to 30 and at a
preconfluency of 90%, which required 5-6 days of culture. Cells were seeded in 24-well
nonpyrogenic, polysterene cell culture plates (Corning Incorporated 3526, NY, USA) at a
density of 105 cells/well. The cells were cultured in a humidified incubator (HeraCell150,
Heraeus, CT, USA) at 37oC and a 5% CO2 and 95% air atmosphere using High glucose
Dulbecco modified Eagle minimal essential medium [High Glucose DMEM 12.78
g/L(Cellgro, Mediatech)] supplemented with heat inactivated calf serum (Gemini BioProducts); 940 mM Na-bicarbonate solution; 20 mM HEPES, 200mM L-Glutamine
(Hyclone), 500 U of penicillin/ml and 500 μg of streptomycin/ml (Gemini Bio-Products),
100mM Na-Pyruvate (Cellgro), Tylosin (10mg/ml; Sigma Chemicals Co., St. Louis,
MO), and G-418 sulfate, an aminoglycoside antibiotic (500mg/ml; Geneticin®, USB
Corporation, USA). The cell culture medium was changed to low Glucose DMEM
15

supplemented with the same components 24 hours before an experiment to induce
expression of SGLT1 (90).

Probiotic Bacteria Culture
The five probiotic Lactobacilli studied were L. acidophilus (ATCC#4356), L.
amylovorus (ATCC#33620), L. gallinarum (ATCC#33199), L. gasseri (ATCC#33323),
and L. johnsonii (ATCC#33200), and were obtained from Wyeth Nutrition (Collegeville,
PA 19426, USA). The working cultures of Lactobacilli were propagated for 48 hours at
37o-C in DeMan, Rogosa and Sharpe (MRS) broth (Difco, Becton-Dickinson, NJ, USA)
in a continuous shaker located inside an anaerobic chamber with an atmosphere of 80%
nitrogen, 10% carbon dioxide, and 10% hydrogen. The bacterial cells were harvested by
centrifugation at 519 rcf for 5 minutes, and were washed twice with sterilized water. The
cells were resuspended in a solution of 80% Dulbecco's Phosphate-Buffered Saline
(DPBS) and 20% glycerol, and stored at -80o-C until used for experiments.

Chemically Defined Media
The composition of the chemically defined medium (CDM) is presented in Table
2.1 and was adapted from that described by Morelli et al.(20). All inorganic salts,
purines, and pyrimidines were purchased in the highest grade available from Sigma
Chemicals Co. (St. Louis, MO). The essential and non-essential amino acid and vitamin
solutions were purchased from Invitrogen (Invitrogen Corporation, USA). A stock CDM
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prepared without any carbohydrate source (pH – 6.5; 400 mOsm) was filter sterilized
using Millipore filters (0.20 µm pore size) and was stored at 0o-C
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Table 2.1. Composition of the Chemically Defined Medium (CDM).
________________________________________________________________________
Component
Concentration (g/L)
________________________________________________________________________
Potassium hydrogen phosphate –
3.1
Di-ammonium hydrogen citrate –

2.0

Potassium dihydrogen phosphate –

1.5

Ascorbic acid –

0.5

Potassium acetate –

10

Tween 80 –

1.0

Heptahydrated magnesium sulfate –

0.5

Hydrated manganese sulfate –

0.02

Cobalt sulfate –

0.5

Calcium Nitrate –

1.0

PABA –

0.002

Biotin –

0.01

Folic acid –

0.002

Guanine –

0.01

Thymine –

0.1

Cytidine –

0.1

2’-deoxyadenosine –

0.1

2’-deoxyuridine –

0.1

Non-Essential Amino Acids Solution 10 mM (100X) –

500 ml

Essential Amino Acids Solution (50X) –

63.5 ml

Vitamin Solution (100X) 200 ml
________________________________________________________________________
The concentration of each component is as g/L unless otherwise stated.
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Selection of Carbohydrate Sources
A preliminary trial was conducted to identify carbohydrates that would support
the growth of L. acidophilus. This was accomplished by adding arabinose, fructose,
glucose, mannose, ribose, and xylose to the CDM at a concentration of 110mM. The
growth of L. acidophilus in MRS broth, which has 110 mM glucose, was used as a
positive control for each experiment. The CDM with different sources of carbohydrates
and MRS were inoculated by adding the L. acidophilus cell suspension (200µL with 109
CFU/ml) to 500 ml of each CDM with the different carbohydrates. The initial optical
density of the culture media was measured after the inoculation was recorded at 600 nm
(Spectramax 384 Plus; Molecular Devices, USA) and anaerobic bacterial growth at 37o-C
every four hours for 80 hours by measuring the increase in optical density. After 80
hours, serial dilutions from each culture flask were plated on MRS agar. After 3-4 d of
anaerobic culture (37o-C) the number of colony forming units (CFU/ml) on the plates
were enumerated and verified as Lactobacilli based on colony morphology and Gram
staining. The CDM, MRS culture media and the MRS agar plates were reduced before
use by placing them in the anaerobic chamber for at least 12 hours.

Preparation of Supernatants from the Lactobacillus Cultures
After defining the growth curve of Lactobacilli in CDM with different
carbohydrate sources, aliquots (100 ml) of each bacterial culture (500 ml) were collected
at three time points corresponding with the start of the exponential phase of growth (32
hours), the mid point of the exponential growth phase (48 hours), and at the start of the
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stationary phase (72 hours). The culture media were centrifuged (11,180 rcf, 15 min, 4oC) to sediment the bacteria. The pH of the cell free supernatants, which was reduced to
4.3-4.5 due to the production of lactic acid and other metabolites during the anaerobic
fermentation, was adjusted to 7.4 with NaOH (10M) using a pH meter (Orion, USA).
This pH is similar to the pH of the DMEM used to culture the Caco-2 cells. To avoid
causing osmotic shock to the Caco-2 cells, the osmolarity of the bacterial culture
supernatant was measured by a vapor pressure osmometer (Wescor, USA) and adjusted
to 400 mOsm to correspond with the osmolarity of the cell culture media. The cell free
supernatants were then filter sterilized (Millipore filters 0.20 µm pore size).
A portion of each supernatant was heated to 100o-C in boiling water for 15 min to
prepare a heated supernatant. After the heat treatment, the supernatant was again
centrifuged (11,180 rcf; 15 min; 4o-C) the pH and osmolarity were measured and
adjusted, if necessary, and filter sterilized.
A preliminary study determined if the bacteria are able to induce a non-genomic
response. To do so, after removal of the supernatant the sedimented bacteria were
resuspended in HBSS-Mannitol.

Glucose Uptake Assay by Caco-2 Cells
After the 24h of culture in low glucose DMEM media, the Caco-2 cells were
washed once with 0.5 ml of 37o-C control solution consisting of glucose-free Hank's
Buffered Salt Solution (HBSS) with 25 mM Mannitol (HBSS-Mannitol) before exposure
to 37o-C control or treatment solutions. The control and treatment solutions were
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removed and replaced with an uptake solution consisting of the control solution to
which was added tracer concentration (2µM) of 14C-D-glucose (PerkinElmer Life And
Analytical Sciences, Inc., Massachusetts 02451 USA). The cells were allowed to
accumulate the labeled glucose for 4 min after which the uptake solution was removed
and the cells were washed twice with 0.5 ml of cold (4º-C) control solution to remove
extracellular 14C-D-glucose not absorbed by the cells. The cells were then lysed by
adding 200µl of 0.1N NaOH, the cell lysates were transferred to scintillation vials,
scintillant (Scintiverse, Fisher Scientific, USA) was added and 14C D-glucose
accumulation was measured by liquid scintillation counting (Liquid Scintillation
Analyzer; Packard, IL, USA).
An initial study evaluated the effect of carbohydrate source on glucose uptake.
This was accomplished by exposing Caco-2 cells for 10 min to the control solution, to
CDM with and without the different carbohydrate sources, and to the MRS broth, without
the addition of bacteria. These solutions were replaced by the uptake solution for 4 min
and glucose accumulation was measured. Another study compared glucose accumulation
by cells exposed for 10 min to HBSS-Mannitol with and without suspended L.
acidophilus before exposure to the uptake solution.
A subsequent study determined the appropriate length of exposure time by
exposing Caco-2 cells for 1, 2.5, 5, 7.5 and 10 min to the supernatant that was present
after culturing L. acidophilus in CDM-fructose for 72 hours before measuring glucose
accumulations. Longer exposure periods were not used to avoid possible synthesis of new
transporters (a genomic response) which would compromise interpretations of a non21

genomic response. This study revealed maximum stimulation of glucose uptake after 10
min of exposure. Therefore, 10 min exposure periods were used for further comparisons.
Additional studies measured glucose accumulation by Caco-2 cells exposed to the
heated and unheated supernatants collected before, during, and after exponential growth
of L. acidophilus (32, 48, and 72 hours, respectively) in CDM-fructose and CDMMannose.
CDM-fructose was used to culture the other probiotic species – L. amylovorus, L.
gallinarum, L. gasseri, and L. johnsonii. The protocol used to culture L. acidophilus was
followed to grow these species and for collection of the supernatant after the exponential
growth phase.

Statistical Analysis
Rates of glucose accumulation (DPM/min) are presented as means ± SEM. Oneway ANOVA was applied to search for an effect of treatment on glucose accumulation
using the PROC GLM procedure of SAS (SAS Institute Inc., Cary, NC, Version 9.1.3).
When a significant treatment effect was detected, specific differences among treatments
were identified by the Duncan's test. A critical value of P < 0.05 was used for all
statistical comparisons.
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RESULTS
Growth of Bacteria
Response to Different Carbohydrates
After 72 hrs of anaerobic incubation the MRS broth contained 109 CFU/ml of L.
acidophilus (Figure 2.1). The growth response of L. acidophilus was similar for CDMfructose and CDM-mannose, but the densities in each after 72 hours (108 CFU/ml) were
lower compared to MRS broth (P<0.0001). Although CDM-glucose elicited an earlier
increase in bacterial densities (shorter lag time), peak densities at 72 hours were not
higher compared with CDM-fructose and CDM-mannose (P<0.004 and P<0.02
respectively). The CDM alone or with arabinose, ribose, and xylose did not support the
growth of L. acidophilus.

Glucose Uptake by Caco-2 Cells
Effects of Culture Media and Different Carbohydrate Sources
Glucose accumulation by Caco-2 cells after 10 min of exposure to MRS broth and
to CDM without carbohydrate and bacteria was decreased by 91% and 82% respectively,
compared to cells exposed to the control solution (HBSS-Mannitol; P<0.05) (Figure 2.2).
Glucose accumulation by the cells was also decreased when the 25 mM mannitol in the
control HBSS was replaced by ribose (16% inhibition), fructose (55% inhibition),
mannose (90% inhibition), and glucose (92% inhibition) (Figure 2.3). Replacement of
mannitol by xylose and arabinose did not reduce glucose uptake. CDM-fructose was used
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for the further studies because it supported the growth of L. acidophilus, but did not
inhibit glucose accumulation as much as the CDM with glucose and mannose.
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Figure. 2.1. Growth curves of Lactobacillus acidophilus.
Lactobacillus acidophilus were grown anaerobically at 37oC for 80 hours in MRS broth
(●) and in chemically defined media with glucose (L), fructose (▼),mannose (■),
arabinose (o), ribose (□), and xylose (♦)as the carbohydrate sources.
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Figure 2.2. Glucose uptake by Caco-2 cells exposed to HBSS-mannitol and different
culture media.
Glucose uptake by Caco-2 cells was measured after exposure to HBSS-mannitol, CDM
without carbohydrate, and MRS broth for 10 min. Rates of glucose uptake (y-axis) are
expressed as a percentage of uptakes by cells exposed to the control solution of 25mM
HBSS-Mannitol. Bars are means ± SE; n = 4 – 24 wells. Bars with different letters are
significantly different.
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Figure 2.3. Effect of different monosaccharides on glucose uptake by Caco-2 cells.
Accumulation of glucose by Caco-2 cells was measured after exposure for 10 min to
HBSS with 25 mM concentrations of different monosaccharides before exposure for 4
min to an uptake solution consisting of HBSS-Mannitol with 2 µM 14C D-glucose.
Glucose uptake is expressed as a percentage of values measured for cells exposed to
25mM HBSS-Mannitol (control cells). Bars are means ± SE; n = 16 - 34 wells. Bars with
different letters are significantly different
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Time Dependent Effect of Supernatant

There was a linear relationship between glucose uptake by Caco-2 cells and
exposure time to the supernatant prepared from CDM-fructose after growth of L
acidophilus for 72 h (Figure 2.4). The 40% increase in glucose uptake after the 10 min

exposure was significant compared to cells exposed to CDM-fructose that had not been
used to grow the bacteria (P<0.05).

Response to CDM-fructose Used to Culture Different Lactobacillus Species

Rates of glucose uptake varied among Caco-2 cells exposed to supernatants of
CDM-fructose after 72 h of culturing the different species of Lactobacilli. All elicited
increased uptakes compared to CDM-fructose before the addition of the bacteria (P<0.05;
Figure 2.5). The greatest stimulation of glucose uptake was measured in response to
CDM-fructose used to grow L. gasseri (83%) followed by L. acidophilus (45%), L.
amylovorus (32%), L. gallinarum (27%), and L. johnsonii (14%).

Effect of Supernatant Collected at Different Stages of Bacterial Growth

The supernatant prepared from CDM-fructose during the exponential phase of
growth of L. acidophilus (48 hours) resulted in the greatest increase in glucose uptake
compared with CDM-fructose without bacteria (83%; Figure 2.6). The supernatant
collected at the stationary phase of growth (72 hours) resulted in a 44% increase in
uptake (P<0.05) whereas the supernatant collected before exponential growth (24 hours)
did not elicit a significant increase in uptake.
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Figure 2.4. The relationship between D-glucose uptake by Caco-2 cells and exposure
time to the supernatant after L. acidophilus has been grown in CDM-fructose
for 72 hours.
Accumulation of D-glucose by Caco-2 cells was measured after exposure for 0 to 10 min
to the supernatant after 72 h of anaerobic growth of Lactobacillus acidophilus in CDMfructose. Values are expressed as a percentage of glucose accumulation by cells exposed
to CDM-fructose before bacterial growth (control cells). Bars are means ± SE; n = 16142 wells. Bars with different letters are significantly different.
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Figure 2.5. D-glucose accumulation by Caco-2 cells exposed for 10 min to the
supernatants after growth of 5 different species of Lactobacillus in CDMfructose.
Accumulation of D-glucose by Caco-2 cells was measured after exposure for 10 min to
the supernatants after 72 h of anaerobic growth of 5 species of Lactobacillus in CDMfructose. Values are expressed as a percentage of glucose accumulation by cells exposed
to CDM-fructose before bacterial growth (control cells). Bars are means ± SE; n = 12143 wells. Bars with different letters are significantly different.
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Figure 2.6. D-glucose by Caco-2 cells exposed for 10 min to the supernatants collected at
different growth phases of L. acidophilus in CDM-fructose.
Accumulation of D-glucose by Caco-2 cells was measured after exposure for 10 min to
the supernatant after 32 (before exponential growth), 48 (mid point of exponential
growth), and 72 h (start of stationary phase) of anaerobic growth of Lactobacillus
acidophilus in CDM-fructose. Values are expressed as a percentage of glucose
accumulation by cells exposed to CDM-fructose before bacterial growth (control cells).
Bars are means ± SE; n = 48-143 wells. Bars with different letters are significantly
different
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Response to Heated Supernatant

Supernatants of CDM-fructose and CDM-mannose after 72 h of L. acidophilus
growth increased glucose uptake by 40% and 93% respectively, compared to cells
exposed to the same media before the addition of bacteria (Figures 2.7 and 2.8). In
contrast, the heated supernatants for both media after culture of the bacteria caused a nonsignificant increase in glucose uptake compared to Caco-2 cells exposed to the two media
before bacterial growth.
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Figure 2.7. D-glucose accumulation by Caco-2 cells exposed to the supernatant when
CDM-fructose was used to culture L. acidophilus.
Glucose accumulation by Caco-2 cells was measured after exposure for 10 min to
CDM-fructose before culture of L. acidophilus and after 72 h of anaerobic growth,
with and without heating (100o-C; 10 min; HSupernatant). Values are expressed as a
percentage of glucose accumulation by cells exposed to CDM-fructose before
bacterial growth (control cells). Bars are means ± SE; n = 62 – 143 wells. Bars with
different letters are significantly different.
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Figure 2.8. D-glucose accumulation by Caco-2 cells exposed to the supernatant when
CDM-mannose was used to culture L. acidophilus.
Glucose accumulation by Caco-2 cells was measured after exposure for 10 min to CDMmannose before and after it was used to culture L. acidophilus for 72 h of anaerobic
growth, with and without heating (100o-C; 10 min; HSupernatant). Values are expressed
as a percentage of glucose accumulation by cells exposed to CDM-Mannose before
bacterial growth (control cells). Bars are means ± SE; n = 8 – 12 wells. Bars with
different letters are significantly different
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DISCUSSION

The interactions between the GIT bacteria and the host can be direct involving
cell-to-cell contacts or indirect by molecules secreted by the bacteria and the host. In this
in-vitro study Caco-2 cells were used as a model for investigating if probiotic
Lactobacilli indirectly via metabolites influence glucose uptake by enterocytes. The

findings demonstrate that metabolites of five species of Lactobacilli cause rapid (nongenomic) increases in glucose uptake by Caco-2 cells. Although not determined, it is
likely the rapid upregulation of glucose transport triggered by the Lactobacilli would be
shared with carriers for other nutrients. Moreover this non-genomic rapid regulation of
glucose transporter proteins does not involve the synthesis of new proteins, but requires
the trafficking of existing transporters from a cytosolic source to the BBM or the
activation of transporters already present in the BBM.
Glucose is considered to be transported across the brush border membrane (BBM)
of enterocytes by a combination of the high affinity, low capacity, concentrative sodium
coupled transporters SGLT1 and the low affinity, high capacity facilitative transporters
GLUT2 (43). Because of the use of tracer concentration of glucose (2 µM), the majority
of glucose uptake measured in the present study would have been absorbed via SGLT1.
This has been verified by the use of inhibitors of SGLT1 (phloridzin) and GLUT2
(phloretin) to study glucose uptake by the same line of Caco-2 cells (Kimura et al.,
unpublished data).
The MRS broth, which is a complete growth medium designed for Lactobacilli
(14), supported the fastest growth and the highest densities of Lactobacilli. However,
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glucose uptake by the Caco-2 cells was depressed 90% by unknown components of the
MRS broth. The most likely candidate was the glucose (110 mM) present in MRS broth,
which would reduce tracer accumulation by competition for the transporters. This led to
the development of a CDM that could be used to culture the bacteria in the presence of
selected carbohydrates. Still, glucose uptake by Caco-2 cells exposed to the CDM
without carbohydrate was reduced 82% compared to cells exposed to the control solution
HBSS-Mannitol. This indicates components of the CDM other than glucose contribute to
the rapid down regulation of the glucose transporters.
The SGLT1 mediated uptake of 14C-D glucose was inhibited when HBSS was
prepared with 25 mM D-ribose, D-fructose, D-mannose and D-glucose by 16%, 55%,
90%, and >90%, respectively, whereas the addition of D-arabinose and D-xylose had no
effect. The most probable explanation for the varying inhibition of SGLT1 activity is that
these carbohydrates compete to varying degrees with the labeled D-glucose for access to
the transporters responsible for absorption of glucose. Even though the solutions were
removed before addition of the uptake solution, it is likely some of the sugar remained,
thereby competing for access to the transporters. Alternatively, the differences may be
related to cellular metabolism of the different sugars and the differential activation of
signaling pathways that trigger the upregulation of glucose transporters. Whereas
enterocytes are capable of metabolizing glucose and fructose (100), ribose (62), and
mannose (19), there is a lack of evidence for enterocyte metabolism of arabinose and
xylose.
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SGLT1 mediates the uptake of D-glucose and D-galactose with similar affinities
(Km = 0.5) (98) whereas the affinity of SGLT1 for D-ribose, D-fructose, D-arabinose,
and D-mannose is negligible. Despite this, Tazawa et. al. (87) showed that D-mannose
and D-fructose reduced the uptake of α-methyl-D-glucopyranoside by COS-7 cells via
SGLT1, corresponding with the results from the present study. Though GLUT-5 is the
main transporter proteins for the uptake of dietary fructose, the uptake of this sugar by
BBM vesicles of rat kidney cells is also mediated by the Na+-dependent glucose
transporter rNaGLT-1 (40). However, this transporter has not been reported in Caco-2
cells. It is possible that D-ribose is able to bind with the SGLT1 at the high
concentrations used and thereby causes the inhibition of tracer glucose uptake in this
study. The lack of inhibition in SGLT1 mediated glucose uptake by D-xylose
corresponds with the low affinity (Km=100mM) (19), which may be shared with Darabinose.
There are several studies that report the potential therapeutic effects of probiotics,
but there are few studies that describe the possible mechanisms by which probiotics
regulate transporter properties and nutrient uptake by the GIT. In one study by Lodemann
et. al. (54), the effects of a diet containing the probiotic strain Enterococcus faecium

NCIMB 10415 on the absorptive and barrier properties of pig intestine were examined
using conventional Ussing chambers. Long term (14-56 days) supplementation of E.
faecium NCIMB 10415 to the diet increased the glucose-dependent short circuit current

(ISC), indicative of increased Na+-coupled glucose transport. Similarly, Breves et. al. (4)
reported the enhanced Na+ dependent glucose uptake by BBM prepared from pig jejunum
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after feeding Saccharomyces boulardii or Bacillus cereus var. toyoi for 8-21 days. The
increase did not involve a change in the Km value, suggesting the response involved in
increase in the densities of SGLT1, not the recruitment of a different type of transporters
(i.e., GLUT2). The long term exposure to these probiotics also caused a significant
increase in transepithelial electrical resistance. These findings support the involvement of
the transcellular pathway of nutrient uptake as the principal mechanisms of glucose
absorption. This is corroborated by the 30% reduction in paracellular permeability after
long term administration of S. boulardii (97). In a recent study by Gilman et. al. (30),
exposing Caco-2 cells to the probiotic Lactobacillus salivarius (UCC 118) for 24 h
increased calcium uptake. The authors proposed the lower pH of the culture media caused
by the production of lactic acids and various short chain fatty acids by the bacteria was a
factor in causing the increase in calcium uptake. Collectively, these studies clearly
demonstrate that long term exposure to probiotic bacteria increases nutrient uptake by
small intestinal epithelial cells.
The long exposure periods to the probiotic bacteria that were used in the above
investigations (from 6 hrs to several days) can be explained by genomic mechanisms that
increase nutrient uptake by the production of more transporter proteins. The rapid
responses to the supernatants measured in the present study demonstrate that metabolites
of probiotic Lactobacilli induce non-genomic responses leading to a rapid increase in the
absorption of glucose and perhaps other nutrients.
Bacteria can interact with host cells by producing metabolites, such as
polyamines, that regulate cell functions including the transport of sugars (42). The
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supernatant after growing L. acidophilus in CDM with carbohydrates for 72 h rapidly
(within 10 min) stimulates glucose uptake by Caco-2 cells. These findings are novel and
demonstrate a heretofore unrecognized interaction between probiotic bacteria and the
host. The identities of the signals in the supernatants and the mechanisms by which they
upregulate carrier mediated uptake of glucose are not known. However, the metabolites
responsible for the increased glucose uptake were heat labile. This suggests the increase
in glucose accumulation was not caused by a depletion of sugars competing for access to
SGLT1, but instead was due to bacterial production of a metabolite that influence cell
functions.
Likely candidates produced by the probiotic lactobacilli include the short chain
fatty acids (SCFA) produced by probiotic bacteria metabolizing carbohydrates and
proteins. SCFA such as butyrate have some regulatory effects on epithelial cells of
gastrointestinal tract (7, 33). SCFA also stimulate the absorption of sodium and water via
the apical Na+/H+ exchanger 3 (NHE3) by modulating the activity and abundance of
NHE3 by genomic mechanisms of adaptation (9, 61, 81). It is therefore possible that
SCFA especially butyrate produced during anaerobic fermentation of carbohydrates by
probiotic bacteria, can rapidly stimulate the activity of glucose transporter proteins
present in the BBM. In one study (86) it was shown that administering SCFA
intraluminally for 3 days increased the mRNA abundances for the facilitative glucose
transporters, GLUT2, and for SGLT1.
Probiotic bacteria also produce polyamines which play a role in the regulation of
ion transport (6). Moreover the interactions between bacteria and enterocytes can elicit
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the synthesis of heat shock proteins (29) which up-regulate enterocyte glucose
transporters (41) and modulate the activity of Na+/H+ exchangers (82). Although this is
exemplary of a genomic response, it provides additional evidence of the ability of
probiotics to influence enterocyte functions
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CHAPTER III
CONCLUSION
The supernatants after culturing probiotic Lactobacilli anaerobically rapidly
upregulated glucose uptake by enterocyte-like Caco-2 cells. Moreover, this in vitro study
supports the concept of rapid non-genomic regulation of BBM glucose transporters by
enterocytes. The concept of non-genomic regulation of nutrient transporters is new and
the mechanisms are not yet well established, but probably involve the rapid translocation
of transporters from the cytosol to the BBM, or the activation of transporters already
present in the BBM. A previous study in our lab showed an upregulatory non-genomic
effect of adenosine and adenosine monophosphate (AMP) on glucose uptake by intact
small intestine (27) and IEC-6 cells (Kimura, personal communications). Interestingly,
Caco-2 cells respond to adenosine with a rapid decrease in glucose uptake.
Further research is needed to verify and extend the findings from the present
study. For example, it will be necessary to determine if other probiotic bacteria influence
the absorption of nutrients by the small intestinal tissue. It will be very important to learn
identify whether the responses are restricted to SGLT1 or if other transporters are
affected It will also be important to understand the relative roles of genomic and nongenomic responses in mediating the transporter responses of enterocytes exposed to
probiotic bacteria.
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The supernatant of L. acidophilus significantly increased the glucose uptake by
Caco-2 cells while the heated supernatant decreased the magnitude of increase in glucose
uptake. My findings indicate the bacterial metabolites responsible for stimulating the
increase in glucose uptake are heat labile and further research is needed to identify the
specific factors. It is possible the regulatory molecules are peptides. If so, it will be
possible to isolate, identify, sequence, and synthesize the peptides, then verify the
efficacy of the peptide in upregulating glucose transport. If the increase in glucose uptake
is triggered by short chain fatty acids produced during the anaerobic fermentation of
carbohydrates by the probiotic bacteria, then further research is needed to identify which
of the short chain fatty acids are responsible, individually or in combination, for the rapid
regulation of transporter proteins in the BBM.
In conclusion, there is a need to better understand how Lactobacilli and other
probiotic bacteria influence nutrient absorption, to identify the signals in the supernatant
that trigger the response, and to define the mechanisms for the response. This information
will help efforts to use probiotic bacteria for the prevention and treatment of several
diseases of the gastrointestinal tract, including diarrhea, inflammatory bowel disease and
other causes of malabsorption.
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